5YOD

Crystal structure of zika virus NS3 protease in complex with a small molecule inhibitor

5YOD の概要

• エントリーDOI: 10.2210/pdb5yod/pdb
• 分子名称: NS2B cofactor, NS3 protease, BENZOIC ACID, ... (4 entities in total)
• 機能のキーワード: non-structural protein 3, serine protease, zika viral protease, viral protein-inhibitor complex, viral protein/inhibitor
• 由来する生物種: Zika virus; 詳細
• タンパク質・核酸の鎖数: 8
• 化学式量合計: 100036.13

構造登録者

Phoo, W.W.,Zhang, Z.Z. (登録日: 2017-10-27, 公開日: 2018-03-21, 最終更新日: 2023-11-22)

主引用文献

Li, Y.,Zhang, Z.,Phoo, W.W.,Loh, Y.R.,Li, R.,Yang, H.Y.,Jansson, A.E.,Hill, J.,Keller, T.H.,Nacro, K.,Luo, D.,Kang, C.
Structural Insights into the Inhibition of Zika Virus NS2B-NS3 Protease by a Small-Molecule Inhibitor
Structure, 26:555-564.e3, 2018

PubMed Abstract: Zika virus (ZIKV) infection has become a global public health concern. The viral NS2B-NS3 protease is an attractive antiviral target because of its role in maturation of viral non-structural proteins. Substrate-derived protease inhibitors have been investigated, but it remains challenging to develop them into drugs. Small-molecule inhibitors are of great interest in antiviral drug development. Here we report the structure and dynamics of ZIKV NS2B-NS3 protease covalently bound to a small-molecule inhibitor. Our crystallographic and NMR studies demonstrate that the inhibitor further stabilizes the closed conformation of ZIKV protease. Upon hydrolysis in situ into two fragments, the benzoyl group of the inhibitor forms a covalent bond with the side chain of catalytic residue S135, whereas the second fragment exhibits no obvious molecular interactions with the protease. This study provides a detailed mechanism of action for a covalent inhibitor, which will guide further development of ZIKV protease inhibitors.

PubMed: 29526431
DOI: 10.1016/j.str.2018.02.005

実験手法

X-RAY DIFFRACTION (1.9 Å)